Picard Medical (PMI) Preferred Stock Liabilities (2024)

Picard Medical (PMI) reported Preferred Stock Liabilities of $20.3 million for Q4 2024.

Picard Medical (PMI) Preferred Stock Liabilities (2024) Analysis & Trends

Picard Medical has reported Preferred Stock Liabilities for 1 years, with the latest figure at $20.3 million in Q4 2024.

  • For the quarter ending Q4 2024, Preferred Stock Liabilities changed N/A year-over-year to $20.3 million; the trailing twelve-month figure through Dec 2024 stood at $20.3 million (changed N/A YoY), and the FY2024 full-year result was $20.3 million, changed N/A from the prior year.
  • Preferred Stock Liabilities for Q4 2024 stood at $20.3 million.
  • The five-year high for Preferred Stock Liabilities was $20.3 million in Q4 2024, with the low at $20.3 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Picard Medical 13.47 Mn 13.47 Mn 275,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2024 20.27 Mn